Amgen Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.1% | +14.1% | +7.9% | +1.1% | -19.0% | +14.7% | -11.8% | +5.0% | -12.9% | +35.6% | -13.3% | |
| – | +0.8% | -0.1% | -7.1% | -0.5% | +13.4% | +63.2% | -5.6% | +0.6% | +19.1% | +37.4% | -7.6% | |
| – | -21.1% | -3.4% | +5.8% | -5.5% | -1.0% | +7.1% | +3.3% | +17.6% | +7.5% | +23.0% | -6.8% | |
| – | -471.7% | – | -226.8% | – | -38.6% | -174.1% | – | -85.6% | – | – | – | |
| – | -36.3% | -99.9% | +790,900.0% | -92.1% | -217.5% | – | – | – | – | – | -183.6% | |
| – | -35.3% | +29.0% | -20.7% | +11.1% | -16.3% | -1.6% | +44.7% | +6.4% | +18.8% | -1.4% | +69.5% | |
| – | -3.6% | +56.1% | -53.5% | – | -60.2% | -194.6% | – | -924.6% | +333.6% | -96.0% | +85.8% | |
| – | +29.4% | +25.1% | +12.2% | +4.2% | +0.1% | +7.0% | +6.9% | +4.6% | +8.6% | +6.1% | +6.0% | |
| – | +1,252.9% | +58.8% | +6.6% | +463.1% | -56.7% | -54.7% | +42.7% | +27.8% | -100.0% | – | -100.0% | |
| – | – | +237.4% | -98.0% | -1,678.9% | +302.7% | – | -67.7% | +733.0% | +297.5% | -113.7% | +38.9% | |
| – | +8.3% | -16.6% | +153.7% | +241.1% | -29.9% | -69.1% | +69.9% | -51.2% | – | -144.7% | +15.3% | |
| – | – | -318.6% | – | +462.6% | -128.9% | – | +652.4% | -120.9% | – | -69.0% | -376.4% | |
| – | +11.6% | +12.9% | +10.5% | +0.4% | -19.2% | +15.9% | -15.2% | +4.8% | -16.2% | +41.2% | -22.1% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.